HEALON, HEALON GV, HEALON5 PRODUCTS SODIUM HYALURONATE OPHTHALMIC VISCOELASTIC DEVICES
Johnson & Johnson Surgical Vision, Inc. · Decision date Jan 14, 1983
What did the FDA approve?
FDA records P810031 as an original PMA application. The recorded decision is approval, dated Jan 14, 1983.
An approval order statement is not included in the imported record. Open the FDA listing for the decision documents.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Ophthalmic
- Decision date
- Jan 14, 1983
Regulatory record facts
- Identifier
- P810031
- Regulatory pathway
- Premarket approval application
- Product code
- LZP
- Decision code
- APPR
- Decision date
- Jan 14, 1983
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: AID, SURGICAL, VISCOELASTIC.
- Product code
- LZP
- FDA device class
- 3
FDA decision timeline
P810031 received
Application receipt date recorded by FDA.
P810031 · FDA decision
APPR
P810031/S083 · Related supplement
Healon EndoCoat PRO Sodium Hyaluronate Ophthalmic Viscoelastic Device (OVD); Healon Duet PRO II Dual Pack Sodium Hya
Timeline entries are records held by MedtechLedger for P810031. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P810031
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 30, 2026 | FDA |
Explore the linked device profile
Other records with product code LZP
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Alcon Laboratories | PMA supplement | Oct 1, 2026 | FDA | |
PROVISC Ophthalmic Viscosurgical DeviceP890047/S072 | Alcon Research, Ltd. | PMA supplement | Oct 1, 2026 | FDA |
| Alcon Research, Ltd. | PMA approval | Sep 26, 1991 | FDA | |
| Alcon Laboratories | PMA approval | Apr 30, 1986 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Johnson & Johnson Surgical Vision, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 31 Technology Dr., Suite 200, Irvine, CA, 92618
Sources and methodology
- Original FDA record: P810031
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



